Please assess the completion status of the following clinical trial:

Trial Title: Effects of Stellate Ganglion Block on Hot Flashes in Hispanic Women With Breast Cancer

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Hispanic or Spanish speaking women aged 30 to 70 years~2. 28 or more reported moderate-to-very severe hot flashes per week~3. a minimum of two weeks of VMS diary recording prior to SGB~4. current use of tamoxifen, aromatase inhibitors, or SERMs for a breast cancer indication for at last six months~5. willingness to undergo fluoroscopy-guided SGB or sham treatment.~6. if participant is on an SSRI,SNRI or membrane stabilizer (pregabalin, gabapentin, for example), it must be a stable, unchanged dose for previous 3 months~Exclusion Criteria:~1. conditions that preclude SGB or sham intervention (e.g., anatomic abnormalities of the anterior neck or cervical spine; goiter, cardiac/pulmonary compromise; acute illness/infection; coagulopathy or bleeding disorder; allergic reactions/contraindications to a local anesthetic or contrast dye); pregnancy 2. use of treatments in the past 2 months that can affect VMS (e.g., use of oral or transdermal HT or contraceptives,~-

- Gender: FEMALE
- Minimum Age: 30 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- Bupivicaine (Type: ACTIVE_COMPARATOR): Stellate Ganglion Block Injection with bupivicaine
- Saline (Type: SHAM_COMPARATOR): Saline injection

Based on this trial design, predict the completion outcome and termination type (if applicable).